FAP and sarcoma: To address the limited efficacy of [225Ac]Ac-FAPI-46 observed in parental FSA tumors and to better recapitulate the high FAP expression in clinical sarcomas [19, 22], we generated FSA cells overexpressing low, medium and high levels of murine FAP (FSA-F).